Lenalid contains Lenalidomide 25mg, a prescription medicine used to treat certain types of blood cancers, including multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL).
| Composition | Lenalidomide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules in 1 Bottle |
| Prescribed For | Multiple myeloma |
| Expiry | December 2027 |
Lenakast (Lenalidomide 25 mg) is an oral immunomodulatory medicine used in the treatment of multiple myeloma and certain blood disorders. It helps slow cancer cell growth, supports immune response, and is commonly used as part of combination therapy under medical supervision.
| Composition | Lenalidomide |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Capsules in 1 Bottle |
| Prescribed For | Multiple myeloma |
| Expiry | December 2027 |
Lenangio contains Lenalidomide 25mg, a medicine used to treat certain types of blood cancers such as multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL).
| Composition | Lenalidomide |
| Manufacturer | Dr Reddy’s Laboratories Ltd |
| Packing | 10 Capsules |
| Prescribed For | Multiple Myeloma, Myelodysplastic Syndrome and Mantle Cell Lymphoma |
| Expiry | December 2027 |
Relidomide 25 capsules contains Lenalidomide 25mg, an immunomodulatory medication primarily used in the treatment of certain blood cancers such as multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma.
| Composition | Lenalidomide 25mg |
| Manufacturer | Reliance Life Sciences |
| Packing | 21 Capsules |
| Prescribed For | Multiple Myeloma |
| Expiry | December 2027 |
